HFCAS OpenIR
'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective
Fu, Liyi1,2,3; Zhang, Yang2,3; Farokhzad, Ryan A.2,3; Mendes, Barbara B.4; Conde, Joao4; Shi, Jinjun2,3
2023-10-11
发表期刊CHEMICAL SOCIETY REVIEWS
ISSN0306-0012
通讯作者Shi, Jinjun()
摘要Nanotechnology has shown tremendous success in the drug delivery field for more effective and safer therapy, and has recently enabled the clinical approval of RNA medicine, a new class of therapeutics. Various nanoparticle strategies have been developed to improve the systemic delivery of therapeutics, among which surface modification of targeting ligands on nanoparticles has been widely explored for 'active' delivery to a specific organ or diseased tissue. Meanwhile, compelling evidence has recently been reported that organ-selective targeting may also be achievable by systemic administration of nanoparticles without surface ligand modification. In this Review, we highlight this unique set of 'passive' nanoparticles and their compositions and mechanisms for organ-selective delivery. In particular, the lipid-based, polymer-based, and biomimetic nanoparticles with tropism to different specific organs after intravenous administration are summarized. The underlying mechanisms (e.g., protein corona and size effect) of these nanosystems for organ selectivity are also extensively discussed. We further provide perspectives on the opportunities and challenges in this exciting area of organ-selective systemic nanoparticle delivery. This review article highlights a unique set of 'passive' nanoparticles for organ-selective systemic delivery and discusses the underlying biological mechanisms.
DOI10.1039/d2cs00998
关键词[WOS]MESSENGER-RNA DELIVERY ; PROTEIN CORONA ; LIPID NANOPARTICLES ; TARGETED DELIVERY ; DRUG-DELIVERY ; MESOSCALE NANOPARTICLES ; LUNG ENDOTHELIUM ; SIRNA DELIVERY ; LIVER ; ADSORPTION
收录类别SCI
语种英语
资助项目J. S. acknowledges the support from the National Institutes of Health grants R01CA200900, R01HL156362, R01HL158097, R01HL159012, R01HL162367, and R33HL168751, and the Innovation Discovery Grants award from the Mass General Brigham. The content is solely th[R01CA200900] ; J. S. acknowledges the support from the National Institutes of Health grants R01CA200900, R01HL156362, R01HL158097, R01HL159012, R01HL162367, and R33HL168751, and the Innovation Discovery Grants award from the Mass General Brigham. The content is solely th[R01HL156362] ; J. S. acknowledges the support from the National Institutes of Health grants R01CA200900, R01HL156362, R01HL158097, R01HL159012, R01HL162367, and R33HL168751, and the Innovation Discovery Grants award from the Mass General Brigham. The content is solely th[R01HL158097] ; J. S. acknowledges the support from the National Institutes of Health grants R01CA200900, R01HL156362, R01HL158097, R01HL159012, R01HL162367, and R33HL168751, and the Innovation Discovery Grants award from the Mass General Brigham. The content is solely th[R01HL159012] ; J. S. acknowledges the support from the National Institutes of Health grants R01CA200900, R01HL156362, R01HL158097, R01HL159012, R01HL162367, and R33HL168751, and the Innovation Discovery Grants award from the Mass General Brigham. The content is solely th[R01HL162367] ; J. S. acknowledges the support from the National Institutes of Health grants R01CA200900, R01HL156362, R01HL158097, R01HL159012, R01HL162367, and R33HL168751, and the Innovation Discovery Grants award from the Mass General Brigham. The content is solely th[R33HL168751] ; National Institutes of Health[848325] ; European Research Council - ERC
项目资助者J. S. acknowledges the support from the National Institutes of Health grants R01CA200900, R01HL156362, R01HL158097, R01HL159012, R01HL162367, and R33HL168751, and the Innovation Discovery Grants award from the Mass General Brigham. The content is solely th ; National Institutes of Health ; European Research Council - ERC
WOS研究方向Chemistry
WOS类目Chemistry, Multidisciplinary
WOS记录号WOS:001078874400001
出版者ROYAL SOC CHEMISTRY
引用统计
被引频次:9[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.hfcas.ac.cn:8080/handle/334002/133436
专题中国科学院合肥物质科学研究院
通讯作者Shi, Jinjun
作者单位1.Chinese Acad Sci, Hefei Inst Phys Sci, Inst Hlth & Med Technol, Hefei 230031, Anhui, Peoples R China
2.Harvard Med Sch, Brigham & Womens Hosp, Ctr Nanomed, Boston, MA 02115 USA
3.Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA
4.Univ Nova Lisboa, Fac Ciencias Med, NOVA Med Sch, ToxOm,NMS FCM, Lisbon, Portugal
推荐引用方式
GB/T 7714
Fu, Liyi,Zhang, Yang,Farokhzad, Ryan A.,et al. 'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective[J]. CHEMICAL SOCIETY REVIEWS,2023.
APA Fu, Liyi,Zhang, Yang,Farokhzad, Ryan A.,Mendes, Barbara B.,Conde, Joao,&Shi, Jinjun.(2023).'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective.CHEMICAL SOCIETY REVIEWS.
MLA Fu, Liyi,et al."'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective".CHEMICAL SOCIETY REVIEWS (2023).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Fu, Liyi]的文章
[Zhang, Yang]的文章
[Farokhzad, Ryan A.]的文章
百度学术
百度学术中相似的文章
[Fu, Liyi]的文章
[Zhang, Yang]的文章
[Farokhzad, Ryan A.]的文章
必应学术
必应学术中相似的文章
[Fu, Liyi]的文章
[Zhang, Yang]的文章
[Farokhzad, Ryan A.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。